A review of hypogonadism and erectile dysfunction among HIV-infected men during the pre- and post-HAART eras: diagnosis, pathogenesis, and management.
Hypogonadism and erectile dysfunction (ED) appear to be more common among men infected with HIV compared to age-matched men within the general U.S. population. HIV providers should consider these conditions and utilize standardized evaluation and diagnostic criteria. Treatment of both hypogonadism and ED increases sexual function and quality of life; testosterone supplementation in the setting of hypogonadism may also improve lean body mass, mental status, and anemia. We review the epidemiology, diagnosis, pathogenesis, and treatment options of both hypogonadism and ED among HIV-infected men.
Crum
Nancy F
NF
Infectious Diseases Division, Naval Medical Center San Diego, San Diego, California 92134-1005, USA. NFCrum@nmcsd.med.navy.mil
Furtek
Kari J
KJ
Olson
Patrick E
PE
Amling
Christopher L
CL
Wallace
Mark R
MR
D023241:Antiretroviral Therapy, Highly Active; D007172:Erectile Dysfunction / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D007006:Hypogonadism / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology; D008297:Male